Literature DB >> 6207426

Monoclonal antibody analysis of diphtheria toxin--II. Inhibition of ADP-ribosyl-transferase activity.

D R Zucker, J R Murphy, A M Pappenheimer.   

Abstract

Monoclonal antibodies directed against the enzymatically active A-fragment of diphtheria toxin were used to investigate further the structure-function relationships within fragment A. Of 16 such antibodies, all but two were directed against epitopes located within the carboxy-terminal 30-40 amino acids of fragment A. Interestingly, the antibodies recognize several epitopes in this small region and varied considerably in their effects on toxin functions. With regard to their effects on the enzymatic activity of fragment A, three types of antibodies were found: (1) antibodies which bind fragment A but fail to inhibit its ADP-ribosyltransferase activity, (2) antibodies which completely inhibit enzyme activity, and (3) antibodies which interact with fragment A to yield antigen-antibody complexes of diminished activity. The results are consistent with location of the catalytic center of fragment A within its carboxy-terminal ca 4000 dalton region.

Mesh:

Substances:

Year:  1984        PMID: 6207426     DOI: 10.1016/0161-5890(84)90166-4

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  5 in total

1.  Expression and immunogenicity of a mutant diphtheria toxin molecule, CRM(197), and its fragments in Salmonella typhi vaccine strain CVD 908-htrA.

Authors:  N Orr; J E Galen; M M Levine
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

2.  Genetic antiviral program against hepatitis C virus.

Authors:  I G Sivov; E I Samokhvalov; V A Knyazhev
Journal:  Dokl Biochem Biophys       Date:  2003 Sep-Oct       Impact factor: 0.788

3.  Structure-function analyses of diphtheria toxin by use of monoclonal antibodies.

Authors:  J M Rolf; L Eidels
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

4.  Towards a recombinant vaccine against diphtheria toxin.

Authors:  K Lobeck; P Drevet; M Léonetti; C Fromen-Romano; F Ducancel; E Lajeunesse; C Lemaire; A Ménez
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

5.  Identification of a human monoclonal antibody to replace equine diphtheria antitoxin for treatment of diphtheria intoxication.

Authors:  Leila M Sevigny; Brian J Booth; Kirk J Rowley; Brett A Leav; Peter S Cheslock; Kerry A Garrity; Susan E Sloan; William Thomas; Gregory J Babcock; Yang Wang
Journal:  Infect Immun       Date:  2013-08-12       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.